SEC Company Response from ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221) (ARTL) — Oct 3, 2018
ARTELO BIOSCIENCES, INC. (ARTL) (CIK 0001621221)
Date: Oct. 3, 2018 · CIK: 0001621221 · Accession: 0001640334-18-001867
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-227571
Letter
Re: Artelo Biosciences, Inc.
artl_corresp.htmOctober 3, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Charlie Guidry
Registration Statement on Form S-1
Filed on September 27, 2018
File No. 333-227571
Acceleration Request
Requested Date: October 5, 2018
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-227571) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Thomas E. Hornish at (858) 350-2392.
* * * *
Sincerely, Artelo Biosciences, Inc.
By: /s/ Gregory D. Gorgas
Show Raw Text
CORRESP
1
filename1.htm
artl_corresp.htmOctober 3, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Charlie Guidry
Re: Artelo Biosciences, Inc.
Registration Statement on Form S-1
Filed on September 27, 2018
File No. 333-227571
Acceleration Request
Requested Date: October 5, 2018
Requested Time: 5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Artelo Biosciences, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-227571) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Thomas E. Hornish at (858) 350-2392.
* * * *
Sincerely, Artelo Biosciences, Inc.
By: /s/ Gregory D. Gorgas
Gregory D. Gorgas
President and Chief Executive Officer
cc: Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C.
Thomas E. Hornish, Wilson Sonsini Goodrich & Rosati, P.C.